Medigen Biotechnology Corp. (TPEX:3176)
Taiwan
· Delayed Price · Currency is TWD 29.80
-0.35 (-1.16%)
Mar 9, 2026, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.15 billion as of March 9, 2026. Its market cap has decreased by -17.68% in one year.
Market Cap
4.15B
Enterprise Value
5.97B
Revenue
1.59B
Ranking
n/a
PE Ratio
n/a
Stock Price
29.80
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.15B, an increase of 506.42%. That is a compound annual growth rate of 8.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Energenesis Biomedical CO.,LTD. | 4.18B |
| Formosa Pharmaceuticals | 4.08B |
| Genovate Biotechnology | 3.98B |
| BioGend Therapeutics | 4.53B |
| Senhwa Biosciences | 4.62B |
| ACRO Biomedical | 3.75B |
| Sagittarius Life Science | 3.51B |
| OBI Pharma | 5.02B |